Table 1.
Study characteristics.
| Author, year | Virus | Country | Institution type | Study type | N patients | N hospital personnel | % female | n female | Mean age (SD) |
|---|---|---|---|---|---|---|---|---|---|
| Angel, 2020 | COVID-19 | United States | Single institution | Retrospective chart review | 98 | 8 | 18.0% | 18 | 57 |
| Barca, 2020 | COVID-19 | Italy | Single institution | Retrospective study | 33 | 27.3% | 9 | 60.53 (range 20–80) | |
| Berardi, 2020 | COVID-19 | Italy | Single institution | Retrospective chart review | 72 | 34.7% | 25 | 64 (53–74) | |
| Bogani, 2020 | COVID-19 | Italy | Single institution | Retrospective review | 5 | 100.0% | 5 | Mean 68yrs (SD 7.1 yrs) | |
| Bundu, 2014 | Ebola | Sierra Leone | Single institution | Retrospective cohort | 8 | – | |||
| Cai, 2020 | COVID-19 | China | Single institution | Descriptive Study | – | ||||
| Cai, 2020 | COVID-19 | China | Single institution | Case series | 7 | 28.6% | 2 | Median age, 60 (IQR, 57–66) | |
| Chao, 2020 | COVID-19 | United States | Multi-institution | Prospective cohort study | 53 | 38.0% | 20 | Mean 62.0 years (±14.3yrs; range 23.5–81.7 yrs) | |
| Chee, 2004 | SARS | Singapore | Single institution | Retrospective chart review | 41 | 124 | – | ||
| Chen, 2020 | COVID-19 | China | Single institution | Case series | 17 | 48 | 100.0% | 17 | Epidural anesthesia patients 29.5 (3.1); General anesthesia patients 28.7 (1.6) |
| Cheung, 2020 | COVID-19 | USA | Single institution | Retrospective cohort | 10 | 20.0% | 2 | 80.5 (67–90) | |
| Chow 2020 | COVID-19 | Hong Kong | Single institution | Retrospective observational | 5 | – | |||
| Couto, 2020 | COVID-19 | United States | Single institution | Retrospective cohort study | 300 | Median 54.6 (range 1–90). Mean age 27. | |||
| Cruz, 2020 | COVID-19 | United States | Single institution | Retrospective review | 14 | 14.3% | 2 | Median 61.9 (range 43–83) | |
| Cui, 2020 | COVID-19 | China | Multi-institution | Case series | 20 | 45.0% | 9 | Median age 63 (range, 32–72) | |
| Deng 2020 | COVID-19 | China | Single institution | Retrospective Observational | 4 | 15 | 50.0% | 2 | 57.5 (14.1) |
| Doglietto, 2020 | COVID-19 | Italy | Single institution | Retrospective matched cohort study | 42 | 56.1% | 23 | Mean 75.95 (SD 15.17) | |
| Doran, 2020 | COVID-19 | United Kingdom | Single institution | Case series | 3 | 0.0% | 0 | 65 (10.4) | |
| Fregatti, 2020 | COVID-19 | Italy | Single institution | Retrospective cohort | 85 | 100.0% | 85 | ||
| Gallego, 2020 | COVID-19 | Spain | Single institution | Prospective cohort study | 189 | 49 | 57.2% | 108 | Elective surgery: 59.5; Urgent surgery: 81 |
| Gao, 2020 | COVID-19 | China | Single institution | Case series | 4 | 25.0% | 1 | 56.8 (11.3) | |
| Garcia-Portabella, 2020 | COVID-19 | Spain | Single institution | Retrospective case series | 11 | 63.6% | 7 | Mean 64.8 (SD 13.5) | |
| Gou, 2020 | COVID-19 | China | Single institution | Case series | 26 | – | |||
| Hassan 2020 | COVID-19 | USA | Single institution | Retrospective study | 91 | 40.7% | 37 | 52.9 (19.3) | |
| He, 2020 | COVID-19 | China | Single institution | Case series | 4 | 25.0% | 1 | 55.75 (range, 51–62) | |
| Huang, 2020 | COVID-19 | China | Single institution | Case series | 3 | 66.7% | 2 | 69.6 (14.6) | |
| Khalafallah, 2020 | COVID-19 | USA | Single institution | Retrospective descriptive | 51 | – | – | ||
| LeBrun, 2020 | COVID-19 | USA | Multi institution | Retrospective cohort | 59 | 75.0% | 44 | 85 (65–100) | |
| Lei, 2020 | COVID-19 | China | Single institution | Retrospective chart review | 34 | 58.8% | 20 | Median age, 55 (IQR, 43–63) | |
| Leong, 2020 | COVID-19 | Singapore | Single institution | Retrospective Descriptive Study | |||||
| Li 2020 | COVID-19 | China | Single-institution | Retrospective observational | 18 | – | |||
| Luong-Nguyen, 2020 | COVID-19 | France | Multi-institution | Retrospective study | 15 | 40.0% | 6 | Median age, 62 (range, 35–68) | |
| Madanelo, 2020 | COVID-19 | Portugal | Single institution | Retrospective chart review | 122 | 32.7% | 40 | 56.93 | |
| Maniscalco 2020 | COVID-19 | Italy | Multi-institution | Retrospective observational | 121 | 73.5% | 89 | 81.8 (NR) | |
| Maniscalco, 2020 | COVID-19 | Italy | Single institution | Retrospective review | 21 | 0 | |||
| Meyer 2020 | COVID-19 | France | Single institution | Prospective observational | 62 | – | |||
| Morrison 2020 | COVID-19 | USA | Single institution | Retrospective observational | 103 | – | |||
| Nazer, 2007 | MERS | Saudi Arabia | Single institution | Case series | 6 | 0.0% | 0 | 63 (18.2) | |
| Ng 2020 | COVID-19 | Singapore | Single institution | Retrospective study | 144 | 8 | – | – | |
| Oh, 2020 | COVID-19 | Korea | Single institution | Case series | 8 | 100.0% | 8 | 30 (25–39) | |
| Paramore 2020 | COVID-19 | UK | Single institution | Prospective observational | 52 | 13.5% | 7 | 66 (NR) | |
| Patel, 2020 | COVID-19 | UK | Single institution | Retrospective review | 75 | 45.0% | 34 | Median 47 (32–63); Mean 59 | |
| Peng, 2020 | COVID-19 | New Zealand | Single institution | Case series | 11 | 27.3% | 3 | Median age, 61 (51–69) | |
| Ralli, 2020 | COVID-19 | Italy | Single institution | Retrospective study | 96 | – | |||
| Rossi, 2020 | COVID-19 | Italy | Single institution | Descriptive Study | 79 | NR | |||
| Saban, 2020 | COVID-19 | Israel | Single institution | Retrospective Review | 142 | 11 | 54.2% | 77 | Mean 72.8 (13.6); Median 74 (range 21–98) |
| Schneider, 2020 | COVID-19 | Germany | Single institution | Retrospective review | 66 | ||||
| Shrikhande, 2020 | COVID-19 | India | Single institution | Prospective observational study | 494 | 65.0% | 321 | Median 48 (range 27–85) | |
| Taha, 2020 | COVID-19 | USA | Single institution | Prospective cohort study | 152 | – | |||
| Tan, 2020 | COVID-19 | China | Single institution | Descriptive study | – | ||||
| Tankel, 2020 | COVID-19 | Israel | Multi-institution | Retrospective comparative study | 130 | 45.4% | 64 | 23.3 (16.8) | |
| Tien, 2005 | SARS | Canada | Single institution | Case series | 4 | 4 | 25.0% | 1 | Median age of 3 patients 58; age of last patient 54 |
| Turri-Zanoni, 2020 | COVID-19 | Italy | Single institution | Case series | 32 | 33.0% | 11 | 62 (range, 32–74) | |
| Valdivia, 2020 | COVID-19 | Spain | Single institution | Retrospective chart review | 50 | 14 | – | – | |
| Wang, 2020 | COVID-19 | USA | Single institution | Case series | 5 | 20.0% | 1 | 52.8 | |
| Wong, 2004 | SARS | Hong Kong | Single institution | Case series | 3 | 100.0% | 3 | – | |
| Yang, 2020 | COVID-19 | China | Single institution | Retrospective chart review | 3 | 100.0% | 3 | Median age, 48 (range, 47–59) | |
| Yang, 2020 | COVID-19 | China | Single institution | Retrospective cohort | 55 | 28 | 32.7% | 18 | 65.1 (13.1) |
| Zagra 2020 | COVID-19 | Italy | Single institution | Retrospective chart review | 664 | ||||
| Zhang 2020 | COVID-19 | China | Single institution | Retrospective observational | 11 | 36.4% | 4 | 66.2 (range 32–93) | |
| Zhang, 2020 | COVID-19 | China | Single institution | Retrospective comparative study | 61 | 100.0% | 61 | (24–40 yrs) |